By Giulia Petroni
Accrol Group said Tuesday that it expects fiscal 2023 results to be at least in line with market views as it continues to perform strongly, and that margins should improve in fiscal 2024.
The U.K. tissue producer said revenue should come in at 241.8 million pounds ($302.17 million) in the year ended April 30 from GBP159.5 million a year prior.
“The group has successfully mitigated the well-reported and substantial inflationary pressures on a broad range of input costs through further process efficiencies and by engaging constructively with its customers to pass-on these additional costs,” it said.
Accrol added that it is well positioned as it enters fiscal 2024, with margins expected to improve back towards pre-pandemic levels supported by investments and revenue mix.
Results for fiscal 2023 are scheduled to be released in late September, according to the company.
Write to Giulia Petroni at giulia.petroni@wsj.com
Read the full article here
